Proximal coronary artery intervention: stent thrombosis, restenosis and death

Fredrik Calais1, Bo Lagerqvist, Jerzy Leppert

  • 1Department of Cardiology, Örebro University Hospital, Örebro, Sweden.

Insights

Percutaneous coronary intervention in the proximal left anterior descending artery (LAD) shows higher restenosis and stent thrombosis compared to the left circumflex artery (LCX). Drug-eluting stents (DES) in the LAD reduced restenosis and mortality versus bare metal stents (BMS).

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Biomedical Engineering

Background:

  • Percutaneous coronary intervention (PCI) in the proximal left anterior descending (LAD) artery may have worse outcomes than in the proximal right coronary artery (RCA) and left circumflex (LCX) arteries.
  • Understanding these differences is crucial for optimizing treatment strategies and patient prognosis.

Purpose of the Study:

  • To compare restenosis, stent thrombosis (ST), and mortality after PCI in the proximal LAD versus proximal RCA and LCX.
  • To evaluate the impact of stent type (bare metal stents [BMS] vs. drug-eluting stents [DES]) on these outcomes.

Main Methods:

  • Analysis of 7840 single-vessel proximal PCI procedures from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR) between May 2005 and May 2011.
  • Comparison of restenosis, ST, and mortality rates between LAD, RCA, and LCX.
  • Stratification of outcomes based on stent type (BMS vs. DES).

Main Results:

  • No significant differences in restenosis or ST were observed between proximal LAD and proximal RCA.
  • Higher rates of restenosis and ST were found in the proximal LAD compared to the proximal LCX (restenosis HR 2.28, ST HR 2.32).
  • In the proximal LAD, DES implantation was associated with significantly lower restenosis (HR 0.39) and mortality (HR 0.58) compared to BMS; this benefit was not observed in the proximal RCA or LCX.

Conclusions:

  • Restenosis is more frequent following PCI in the proximal LAD compared to the proximal LCX.
  • Drug-eluting stent use in the proximal LAD is associated with reduced risks of restenosis and death compared to bare metal stents.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
450
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
2.1K
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
525
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
954
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
1.1K
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
659